Trilaciclib
Back to search| Scientific Name: | Trilaciclib |
| Brand Name: | Cosela |
| Company Owner: | Not Available |
| Mechanism Of Action | Trilaciclib is inhibits cyclin-dependant kinase 4 (CDK4) at a concentration of 1 nmol/L and cyclin-dependent kinase 5 (CDK5) at 4 nmol/L. |
| Description of the Drug: | Trilaciclib is a CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression. |
| Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB15442
